Brown & Brown (BRO)
(Delayed Data from NYSE)
$99.17 USD
+1.74 (1.79%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $99.16 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum D VGM
Brown & Brown (BRO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$97.18 | $112.00 | $86.00 | -0.26% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Brown & Brown comes to $97.18. The forecasts range from a low of $86.00 to a high of $112.00. The average price target represents a decline of 0.26% from the last closing price of $97.43.
Analyst Price Targets (11)
Broker Rating
Brown & Brown currently has an average brokerage recommendation (ABR) of 2.31 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 2.25 a month ago based on 12 recommendations.
Of the 13 recommendations deriving the current ABR, four are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 30.77% and 15.38% of all recommendations. A month ago, Strong Buy made up 33.33%, while Buy represented 16.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 6 | 6 | 5 | 5 | 4 |
Sell | 1 | 1 | 1 | 1 | 2 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.31 | 2.31 | 2.25 | 2.25 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/26/2024 | Keefe Bruyette & Woods | Meyer Shields | Moderate Sell | Moderate Sell |
7/24/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
7/24/2024 | Truist Securities | Mark D Hughes | Strong Buy | Strong Buy |
7/23/2024 | William Blair | Adam Klauber | Hold | Hold |
7/12/2024 | Goldman Sachs | Robert A Cox | Strong Buy | Strong Buy |
7/11/2024 | BMO Capital Markets | Michael Zaremski | Strong Buy | Strong Buy |
7/11/2024 | Wells Fargo Securities | Elyse Greenspan | Hold | Hold |
7/9/2024 | Dowling & Partners | Joe Oscar Christiana | Not Available | Hold |
4/16/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/26/2024 | Raymond James | Charles G Peters | Moderate Buy | Moderate Buy |
1/29/2024 | UBS | Brian R Meredith | Hold | Hold |
1/9/2024 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.31 |
ABR (Last week) | 2.31 |
# of Recs in ABR | 13 |
Average Target Price | $99.18 |
LT Growth Rate | 11.00% |
Industry | Insurance - Brokerage |
Industry Rank by ABR | 32 of 252 |
Current Quarter EPS Est: | 0.86 |